Comment on

• Elevated serum levels of S100 and survival in metastatic malignant melanoma.

  Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Wittke F, Hoffmann R, Ganser A, Atzpodien J. Buer J, et al. Br J Cancer. 1997;75(9):1373-6. doi: 10.1038/bjc.1997.232. Br J Cancer. 1997. PMID: 9155061 Free PMC article. Clinical Trial.
• Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

  Dettmar P, Harbeck N, Thomssen C, Pache L, Ziffer P, Fizi K, Jänicke F, Nathrath W, Schmitt M, Graeff H, Höfler H. Dettmar P, et al. Br J Cancer. 1997;75(10):1525-33. doi: 10.1038/bjc.1997.261. Br J Cancer. 1997. PMID: 9166949 Free PMC article.
• Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

  Ferrandina G, Scambia G, Bardelli F, Benedetti Panici P, Mancuso S, Messori A. Ferrandina G, et al. Br J Cancer. 1997;76(5):661-6. doi: 10.1038/bjc.1997.442. Br J Cancer. 1997. PMID: 9303368 Free PMC article.